These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9609529)

  • 1. Distinction of eosinophilic leukaemia from idiopathic hypereosinophilic syndrome by analysis of Wilms' tumour gene expression.
    Menssen HD; Renkl HJ; Rieder H; Bartelt S; Schmidt A; Notter M; Thiel E
    Br J Haematol; 1998 May; 101(2):325-34. PubMed ID: 9609529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Wilms tumor gene (WT1) expression in acute leukemia patients with special reference to the differential diagnosis between eosinophilic leukemia and idiopathic hypereosinophilic syndromes.
    Menssen HD; Schmidt A; Bartelt S; Arjomand A; Thomsen H; Leben R; Kath R; Thiel E
    Leuk Lymphoma; 2000 Jan; 36(3-4):285-94. PubMed ID: 10674900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia.
    Cilloni D; Messa F; Martinelli G; Gottardi E; Arruga F; Defilippi I; Carturan S; Messa E; Fava M; Giugliano E; Rosso V; Catalano R; Merante S; Nicoli P; Rondoni M; Ottaviani E; Soverini S; Tiribelli M; Pane F; Baccarani M; Saglio G
    Leukemia; 2007 Jul; 21(7):1442-50. PubMed ID: 17508006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias.
    Kreuzer KA; Saborowski A; Lupberger J; Appelt C; Na IK; le Coutre P; Schmidt CA
    Br J Haematol; 2001 Aug; 114(2):313-8. PubMed ID: 11529849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
    Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
    Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome.
    Wang SA; Hasserjian RP; Tam W; Tsai AG; Geyer JT; George TI; Foucar K; Rogers HJ; Hsi ED; Rea BA; Bagg A; Bueso-Ramos CE; Arber DA; Verstovsek S; Orazi A
    Haematologica; 2017 Aug; 102(8):1352-1360. PubMed ID: 28495918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases.
    La Starza R; Specchia G; Cuneo A; Beacci D; Nozzoli C; Luciano L; Aventin A; Sambani C; Testoni N; Foppoli M; Invernizzi R; Marynen P; Martelli MF; Mecucci C
    Haematologica; 2005 May; 90(5):596-601. PubMed ID: 15921374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias.
    Siehl JM; Thiel E; Heufelder K; Snarski E; Schwartz S; Mailänder V; Keilholz U
    Br J Haematol; 2003 Oct; 123(2):235-42. PubMed ID: 14531904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome.
    Bain BJ
    Br J Haematol; 1996 Oct; 95(1):2-9. PubMed ID: 8857931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms tumor gene (WT1) expression as a panleukemic marker.
    Menssen HD; Siehl JM; Thiel E
    Int J Hematol; 2002 Aug; 76(2):103-9. PubMed ID: 12215007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro.
    Maurer U; Brieger J; Weidmann E; Mitrou PS; Hoelzer D; Bergmann L
    Exp Hematol; 1997 Aug; 25(9):945-50. PubMed ID: 9257807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells.
    Hosen N; Sonoda Y; Oji Y; Kimura T; Minamiguchi H; Tamaki H; Kawakami M; Asada M; Kanato K; Motomura M; Murakami M; Fujioka T; Masuda T; Kim EH; Tsuboi A; Oka Y; Soma T; Ogawa H; Sugiyama H
    Br J Haematol; 2002 Feb; 116(2):409-20. PubMed ID: 11841446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.
    Wang SA; Tam W; Tsai AG; Arber DA; Hasserjian RP; Geyer JT; George TI; Czuchlewski DR; Foucar K; Rogers HJ; Hsi ED; Bryan Rea B; Bagg A; Dal Cin P; Zhao C; Kelley TW; Verstovsek S; Bueso-Ramos C; Orazi A
    Mod Pathol; 2016 Aug; 29(8):854-64. PubMed ID: 27174585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses.
    Smith KJ; Jacobson E; Hamza S; Skelton H
    Arch Dermatol; 2004 May; 140(5):584-8. PubMed ID: 15148104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study.
    Østergaard M; Olesen LH; Hasle H; Kjeldsen E; Hokland P
    Br J Haematol; 2004 Jun; 125(5):590-600. PubMed ID: 15147374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia.
    Hämäläinen MM; Kairisto V; Juvonen V; Johansson J; Aurén J; Kohonen K; Remes K; Salmi TT; Helenius H; Pelliniemi TT
    Eur J Haematol; 2008 Mar; 80(3):201-7. PubMed ID: 18081724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studying of clinical and laboratory features of chronic eosinophilic leukemias /hypereosinophilic syndrome].
    Zhang Y; Yu MH; Xu SC; Yang L; Yu Y; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):3-8. PubMed ID: 18512307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient.
    Pritchard-Jones K; Renshaw J; King-Underwood L
    Hum Mol Genet; 1994 Sep; 3(9):1633-7. PubMed ID: 7833922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of Wilms' tumor gene (WT1) in leukemias and its clinical implication].
    Wu X; Wang Y; Pei X
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):16-9. PubMed ID: 10921096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identical genetic changes in different histologic components of Wilms' tumors.
    Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
    J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.